Consun Pharmaceutical Group Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Consun Pharmaceutical Group heeft een totaal eigen vermogen van CN¥4.0B en een totale schuld van CN¥507.7M, wat de schuld-eigenvermogensverhouding op 12.7% brengt. De totale activa en totale passiva bedragen respectievelijk CN¥5.5B en CN¥1.5B. De EBIT Consun Pharmaceutical Group is CN¥882.9M waardoor de rentedekking -16.8 is. Het heeft contanten en kortetermijnbeleggingen van CN¥3.6B.
Belangrijke informatie
12.7%
Verhouding schuld/eigen vermogen
CN¥507.70m
Schuld
| Rente dekkingsratio | -16.8x |
| Contant | CN¥3.58b |
| Aandelen | CN¥3.99b |
| Totaal verplichtingen | CN¥1.50b |
| Totaal activa | CN¥5.49b |
Recente financiële gezondheidsupdates
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
Jun 12
Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Recent updates
Consun Pharmaceutical Group Limited's (HKG:1681) Shares Leap 32% Yet They're Still Not Telling The Full Story
Oct 02Here's Why Consun Pharmaceutical Group (HKG:1681) Has Caught The Eye Of Investors
Sep 26Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
Jun 12Consun Pharmaceutical Group's (HKG:1681) Dividend Will Be CN¥0.30
May 12Consun Pharmaceutical Group (HKG:1681) Is Increasing Its Dividend To CN¥0.30
Jun 01Consun Pharmaceutical Group (HKG:1681) Has A Rock Solid Balance Sheet
May 04Consun Pharmaceutical Group (HKG:1681) Will Pay A Dividend Of HK$0.20
Apr 28Consun Pharmaceutical Group (HKG:1681) Has Announced A Dividend Of HK$0.20
Apr 07Consun Pharmaceutical Group (HKG:1681) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Aug 26Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Rather Sparingly
Apr 21Does It Make Sense To Buy Consun Pharmaceutical Group Limited (HKG:1681) For Its Yield?
Mar 17Here's Why Consun Pharmaceutical Group's (HKG:1681) Statutory Earnings Are Arguably Too Conservative
Feb 19How Much Did Consun Pharmaceutical Group's(HKG:1681) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 29Could The Consun Pharmaceutical Group Limited (HKG:1681) Ownership Structure Tell Us Something Useful?
Jan 08
Consun Pharmaceutical Group (HKG:1681) Seems To Use Debt Quite Sensibly
Dec 18Should Consun Pharmaceutical Group Limited (HKG:1681) Be Part Of Your Income Portfolio?
Nov 18Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( CN¥4.2B ) 1681 } overtreffen de korte termijn passiva ( CN¥1.4B ).
Langlopende schulden: De kortetermijnactiva 1681 ( CN¥4.2B ) overtreffen de langetermijnschulden ( CN¥112.5M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 1681 heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van 1681 is de afgelopen 5 jaar gedaald van 27.7% naar 12.7%.
Schuldendekking: De schuld van 1681 wordt goed gedekt door de operationele kasstroom ( 180.3% ).
Rentedekking: 1681 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.